33 employees
Aridis is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases.
1995
Aridis Pharmaceuticals raised undisclosed on January 27, 2022
Investors: Bill & Melinda Gates Foundation
Aridis Pharmaceuticals raised undisclosed on June 6, 2018
Investors: Efung Capital